Outcome of Off-Label AREDS 2 Supplementation for the Treatment of Macular Degeneration in Non-Proliferative Idiopathic Type 2 Macular Telangiectasia

por Berger, Tyler A, Manry, Matthew W, Lindsell, Lucas B, Osher, James M, Miller, Daniel M, Foster, Robert E, Riemann, Christopher D, Petersen, Michael R, Sisk, Robert A
Publicado 2021